ENDRA Life Sciences (NDRA) Total Liabilities (2016 - 2026)

ENDRA Life Sciences (NDRA) has 11 years of Total Liabilities data on file, last reported at $1.7 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $1.7 million, up 16.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 16.48% YoY), and the FY2025 annual result was $1.6 million, down 15.77% from the prior year.
• Total Liabilities advanced to $1.7 million in Q1 2026 per NDRA's latest filing, from $1.6 million in the prior quarter.
• Over five years, Total Liabilities peaked at $2.4 million in Q3 2023 and troughed at $1.1 million in Q4 2023.
• A 5-year average of $1.8 million and a median of $1.8 million in 2025 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities surged 78.48% in 2022, then slumped 47.08% in 2023.
• A 5-year view of Total Liabilities shows it stood at $2.1 million in 2022, then plunged by 47.08% to $1.1 million in 2023, then surged by 72.76% to $1.9 million in 2024, then decreased by 15.77% to $1.6 million in 2025, then climbed by 3.62% to $1.7 million in 2026.
• Business Quant data shows NDRA's Total Liabilities at $1.7 million in Q1 2026, $1.6 million in Q4 2025, and $1.8 million in Q3 2025.